APA (7th ed.) Citation

Li, C. Y., Zhong, L., Chen, D. G., Yao, F. S., & Yan, H. (2025). VRd vs. VPd as induction therapy in high risk newly diagnosed multiple myeloma. Scientific reports, 15(1), 9946-8. https://doi.org/10.1038/s41598-025-85398-0

Chicago Style (17th ed.) Citation

Li, Chun Yan, Long Zhong, Dan Gui Chen, Fu Sheng Yao, and Hong Yan. "VRd Vs. VPd as Induction Therapy in High Risk Newly Diagnosed Multiple Myeloma." Scientific Reports 15, no. 1 (2025): 9946-8. https://doi.org/10.1038/s41598-025-85398-0.

MLA (9th ed.) Citation

Li, Chun Yan, et al. "VRd Vs. VPd as Induction Therapy in High Risk Newly Diagnosed Multiple Myeloma." Scientific Reports, vol. 15, no. 1, 2025, pp. 9946-8, https://doi.org/10.1038/s41598-025-85398-0.